Furthermore, a targeted drug for ACTC1, DEXAMETHASONE, is commonly used in cancer treatment to alleviate side effects induced by cancer therapy, control cancer-related inflammation and immune responses as part of cancer treatment. The gene discussed is ACTC1; the disease is cancer.